Suppression of pro-inflammatory T-cell responses by human mesothelial cells

Nephrology Dialysis Transplantation

Volumn 28, Issue 7, 2013, Pages 1743-1750

  Lin, Chan Yu ^a,b   Kift Morgan, Ann ^a   Moser, Bernhard ^a   Topley, Nicholas ^a   Eberl, Matthias ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

T lymphocytes; Inflammation; Mesothelial cells; Peritoneal dialysis; TGF

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; 4 HYDROXY 3 METHYL BUT 2 ENYL PYROPHOSPHATE; ACTIVIN; ACTIVIN A; CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; ISOPRENOID; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXOSOME; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MESOTHELIUM CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ΓΔ T LYMPHOCYTES; INFLAMMATION; MESOTHELIAL CELLS; PERITONEAL DIALYSIS; TGF-Β;

BLOTTING, WESTERN; CELLS, CULTURED; CYTOKINES; DIPHOSPHATES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; OMENTUM; PERITONEAL DIALYSIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884515003     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs612     Document Type: Article

References (42)

1. Piraino B, Bernardini J, Brown E et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 2011; 31: 614-630
2. Johnson DW, Brown FG, Clarke M et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol 2012; 23: 1097-1107
3. Boudville N, Kemp A, Clayton P et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol 2012; 23: 1398-1405
4. Yung S, Chan TM. Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells. Mediators Inflamm 2012; 2012: 484167
5. Yáñez-Mó M, Lara-Pezzi E, Selgas R et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-413
6. Offner FA, Feichtinger H, Stadlmann S et al. Transforming growth factor-β synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996; 148: 1679-1688
7. Ksiazek K, Winckiewicz M, Staniszewski R et al. Correlation between the donor age and the proliferative lifespan of human peritoneal mesothelial cells in vitro: is TGF-β1 a link? Exp Gerontol 2007; 42: 840-843
8. Abendstein B, Stadlmann S, Knabbe C et al. Regulation of transforming growth factor-β secretion by human peritoneal mesothelial and ovarian carcinoma cells. Cytokine 2000; 12: 1115-1119
9. Mlambo NC, Hylander B, Brauner A. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis. Inflammation 1999; 23: 131-139
10. Lai KN, Lai KB, Lam CW et al. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 35: 644-652
11. Eberl M, Moser B. Monocytes and γδ T cells: close encounters in microbial infection. Trends Immunol 2009; 30: 562-568
12. Riganti C, Massaia M, Davey MS et al. Human γδ T-cell responses in infection and immunotherapy: common mechanisms, common mediators? Eur J Immunol 2012; 42: 1668-1676
13. Morita CT, Jin C, Sarikonda G et al. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 2007; 215: 59-76
14. Davey MS, Tyrrell JM, Howe RA et al. A promising target for treatment of multidrug-resistant bacterial infections. Antimicrob Agents Chemother 2011; 55: 3635-3636
15. Davey MS, Lin CY, Roberts GW et al. Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog 2011; 7: e1002040
16. Eberl M, Roberts GW, Meuter S et al. A rapid crosstalk of human γδ T cells and monocytes drives the acute inflammation in bacterial infections. PLoS Pathog 2009; 5: e1000308
17. Bonneville M, O'Brien RL, Born WK. γδ T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 2010; 10: 467-478
18. Welton JL, Morgan MP, Martí S et al. Monocytes and γδ T cells control the acute phase response to intravenous zoledronate: Insights from a phase IV safety trial. J Bone Miner Res 2013 (in press); doi:10.1002/jbmr.1797
19. Martinet L, Fleury-Cappellesso S, Gadelorge M et al. A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells. Eur J Immunol 2009; 39: 752-762
20. Martinet L, Jean C, Dietrich G et al. PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling. Biochem Pharmacol 2010; 80: 838-845
21. Rojas RE, Balaji KN, Subramanian A et al. Regulation of human CD4+ αβ T-cell-receptor-positive (TCR+) and γδ TCR+ T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor β. Infect Immun 1999; 67: 6461-6472
22. + γδ cell immunosuppression by TGF- β: relevance for cancer immunotherapy. J Immunol 2010; 184: 6680-6687
23. Topley N, Brown Z, Jörres A et al. Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin- 1β and tumor necrosis factor-α. Am J Pathol 1993; 142: 1876-1886
24. Colmont CS, Raby AC, Dioszeghy V et al. Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors. Nephrol Dial Transplant 2011; 26: 4079-4090
25. + cells a mass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol 2009; 39: 1893-1901
26. Roberts GW, Baird D, Gallagher K et al. Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysis. J Am Soc Nephrol 2009; 20: 1895-1900
27. Reichenberg A, Hintz M, Kletschek Y et al. Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human γδ T cells but does not lead to competitive antagonism. Bioorg Med Chem Lett 2003; 13: 1257-1260
28. Clayton A, Mitchell JP, Court J et al. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res 2007; 67: 7458-7466
29. Webber J, Steadman R, Mason MD et al. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 2010; 70: 9621-9630
30. Clayton A, Al-Taei S, Webber J et al. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol 2011; 187: 676-683
31. Inman GJ, Nicolás FJ, Callahan JF et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62: 65-74
32. Akhurst RJ, Hata A. Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov 2012; 11: 790-811
33. Yung S, Thomas GJ, Stylianou E et al. Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. Am J Pathol 1995; 146: 520-529
34. Shah S, Lowery E, Braun RK et al. Cellular basis of tissue regeneration by omentum. PLoS One 2012; 7: e38368
35. Kariyawasam HH, Semitekolou M, Robinson DS et al. Activin-A: a novel critical regulator of allergic asthma. Clin Exp Allergy 2011; 41: 1505-1514
36. Hedger MP, Winnall WR, Phillips DJ et al. The regulation and functions of activin and follistatin in inflammation and immunity. Vitam Horm 2011; 85: 255-297
37. Antsiferova M, Huber M, Meyer M et al. Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response. Nat Commun 2011; 2: 576
38. Bergmann L, Schui DK, Brieger J et al. The inhibition of lymphokine-activated killer cells in acute myeloblastic leukemia is mediated by transforming growth factor-beta 1. Exp Hematol 1995; 23: 1574-1580
39. Eriksson M, Meadows SK, Wira CR et al. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-β. J Leukoc Biol 2004; 76: 667-675
40. Wilson EB, El-Jawhari JJ, Neilson AL et al. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity. PLoS ONE 2011; 6: e22842
41. Hurst SM, Wilkinson TS, McLoughlin RM et al. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14: 705-714
42. McLoughlin RM, Witowski J, Robson RL et al. Interplay between IFN-γ and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest 2003; 112: 598-607